Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells

Brain

Volumn 120, Issue 6, 1997, Pages 929-938

  Behrens, Lüder ^a   Bender, Anke ^a   Johnson, Margaret A ^c   Hohlfeld, Reinhard ^a,b  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cytotoxicity; Inflammation; Myositis; T cells

Indexed keywords

CD56 ANTIGEN; CELL NUCLEUS DNA; DNA FRAGMENT; FAS ANTIGEN; NERVE CELL ADHESION MOLECULE; PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEDIATED CYTOTOXICITY; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DERMATOMYOSITIS; DNA DETERMINATION; DUCHENNE MUSCULAR DYSTROPHY; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; INFLAMMATORY CELL; MALE; MUSCLE BIOPSY; MUSCLE CELL; MYOPATHY; MYOSITIS; POLYMYOSITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; BIOTIN; CHILD, PRESCHOOL; DERMATOMYOSITIS; DNA FRAGMENTATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCULAR DYSTROPHIES; PROTO-ONCOGENE PROTEINS C-BCL-2; STAINING AND LABELING; T-LYMPHOCYTES; URACIL NUCLEOTIDES;

EID: 0030918667     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.6.929     Document Type: Article

References (49)

1. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. III. Immunoelectron microscopy aspects of cell-mediated muscle fibre injury. Ann Neurol 1986; 19: 112-25.
2. + T cells. J Exp Med 1995; 181; 1863-8.
3. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. [Review]. Annu Rev Immunol 1994: 12: 735-73.
4. Berke G. The CTL's kiss of death. [Review]. Cell 1995; 81: 9-12.
5. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas [see comments]. Nature 1995; 373: 441-4. Comment in: Nature 1995; 373: 385-6.
6. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas [see comments]. Nature 1995; 373: 441-4. Comment in: Nature 1995; 373: 385-6.
7. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995; 37 Suppl: S74-86.
8. De Bleecker JL, Engel AG. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am J Pathol 1995; 146: 1178-87.
9. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989; 20: 224-31.
10. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16: 209-15.
11. Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill, 1994: 1335-83.
12. Farrow SN, Brown R. New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev 1996; 6: 45-9.
13. Fraser A, Evan G. A license to kill. [Review]. Cell 1996; 85: 781-4.
14. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 1996; 133: 335-43.
15. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
16. Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, et al. Differential expression of perform in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 97: 2905-10.
17. Griffiths GM. The cell biology of CTL killing. [Review]. Curr Opin Immunol 1995: 7: 343-8.
18. Hockenbery D. Defining apoptosis [comment] [see comments]. [Review]. Am J Pathol 1995; 146: 16-9. Comment on: Am J Pathol 1995: 146: 3-15, Comment in: Am J Pathol 1995; 146: 1-2.
19. Hockenbery D. Defining apoptosis [comment] [see comments]. [Review]. Am J Pathol 1995; 146: 16-9. Comment on: Am J Pathol 1995: 146: 3-15, Comment in: Am J Pathol 1995; 146: 1-2.
20. Hockenbery D. Defining apoptosis [comment] [see comments]. [Review]. Am J Pathol 1995; 146: 16-9. Comment on: Am J Pathol 1995: 146: 3-15, Comment in: Am J Pathol 1995; 146: 1-2.
21. Hohlfeld R, Engel AG. The immunobiology of muscle. [Review]. Immunol Today 1994; 15: 269-74.
22. Illa I, Leon-Monzon M, Dalakas MC. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells. Ann Neurol 1992; 31: 46-52.
23. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528-30.
24. Kane AB. Redefining cell death [editorial; comment]. Am J Pathol 1995; 146: 1-2. Comment on: Am J Pathol 1995; 146: 3-15, Comment on: Am J Pathol 1995; 146: 16-9.
25. Kane AB. Redefining cell death [editorial; comment]. Am J Pathol 1995; 146: 1-2. Comment on: Am J Pathol 1995; 146: 3-15, Comment on: Am J Pathol 1995; 146: 16-9.
26. Kane AB. Redefining cell death [editorial; comment]. Am J Pathol 1995; 146: 1-2. Comment on: Am J Pathol 1995; 146: 3-15, Comment on: Am J Pathol 1995; 146: 16-9.
27. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988; 23: 64-72.
28. Lee RK, Spielman J, Podack ER. bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int Immunol 1996; 8: 991-1000.
29. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69: 415-29.
30. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. [Review]. Immunol Today 1995; 16: 569-74.
31. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death [see comments]. [Review]. Am J Pathol 1995; 146: 3-15. Comment in: Am J Pathol 1995; 146: 1-2, Comment in: Am J Pathol 1995; 146: 16-9.
32. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death [see comments]. [Review]. Am J Pathol 1995; 146: 3-15. Comment in: Am J Pathol 1995; 146: 1-2, Comment in: Am J Pathol 1995; 146: 16-9.
33. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death [see comments]. [Review]. Am J Pathol 1995; 146: 3-15. Comment in: Am J Pathol 1995; 146: 1-2, Comment in: Am J Pathol 1995; 146: 16-9.
34. Mantegazza R, Andreetta F, Bernasconi P, Baggi F, Oksenberg JR, Simoncini O, et al. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. J Clin Invest 1993; 91: 2880-6.
35. Nagata S, Golstein P. The Fas death factor. [Review]. Science 1995; 267: 1449-56.
36. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. Predominant TCR-αβ variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 1994; 152: 2569-76.
37. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993; 143: 446-52.
38. Schneider C, Gold R, Dalakas MC, Schmied M, Lassmann H, Toyka KV, et al. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis and inclusion body myositis. J Neuropathol Exp Neurol 1996; 55: 1205-9.
39. Schubert W, Zimmermann K, Cramer M, Starzinski-Powitz A. Lymphocyte antigen Leu-19 as a marker of regeneration in human skeletal muscle. Proc Natl Acad Sci USA 1989; 86: 307-11.
40. Schwartz SM, Bennett MR. Death by any other name [comment]. Am J Pathol 1995; 147: 229-34. Comment on: Am J Pathol 1995; 147: 251-66, Comment on: Am J Pathol 1995; 147: 267-77.
41. Schwartz SM, Bennett MR. Death by any other name [comment]. Am J Pathol 1995; 147: 229-34. Comment on: Am J Pathol 1995; 147: 251-66, Comment on: Am J Pathol 1995; 147: 267-77.
42. Schwartz SM, Bennett MR. Death by any other name [comment]. Am J Pathol 1995; 147: 229-34. Comment on: Am J Pathol 1995; 147: 251-66, Comment on: Am J Pathol 1995; 147: 267-77.
43. Scott J. A place in the world of RNA editing. [Review]. Cell 1995; 81: 833-6.
44. Steller H. Mechanisms and genes of cellular suicide. [Review]. Science 1995; 267: 1445-9.
45. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301-5.
46. Vaux DL, Strasser A. The molecular basis of apoptosis. [Review]. Proc Natl Acad Sci USA 1996; 93: 2239-44.
47. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. [Review]. Cell 1994; 76: 777-9.
48. Wang J, Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 1996; 273: 359-61.
49. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747-56.